Press release
Lizhuo Pharmaceutical Technology: Empagliflozin Intermediate 3 CAS NO. 1279691-36-9
Image: https://www.abnewswire.com/upload/2025/02/244d490e8e67be1fc6fd489f30405e07.jpg
CAS NO.:1279691-36-9
Synonyms:
Empagliflozin N-1;
(2S,3R,4S,5S,6R)-2-(3-(4-((S)-tetrahydrofuran-3-yloxy)benzyl)-4-chlorophenyl)-tetrahydro-6-(hydroxyMethyl)-2-Methoxy-2H-pyran-3,4,5-triol;
Methyl 1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]Methyl]phenyl]-alpha-D-glucopyranoside;
Related Categories:Empagliflozin intermediates; pharmaceutical raw materials; pharmaceutical intermediates; organic intermediates.
Appearance: White to Off-White solid
Purity: 98%
Application: Empagliflozin intermediates;pharmaceutical intermediate
Supply Ability
Empagliflozin Intermediate3 CAS NO.1279691-36-9 is our regularly production product, whether you need small sample or a large cargo of more than tonnage, our company can supply it formally
If you are interested in Empagliflozin Intermediate3 CAS NO.1279691-36-9, feel freely contact us please, and we will provide you the best quality products, reasonable price and best service, expecting to our cooperation.
Company Profile
Shanghai Lizhuo Pharmaceutical Technology Co., Ltd. is a subsidiary of Shenzhen Rich Chemical Technology Co., Ltd., located in Shanghai. Since its establishment, Lizhuo Pharmaceutical has been committed to providing global pharmaceutical companies and new drug research and development institutions with comprehensive solutions from early product development to drug listing. R&D, customization and production services of pharmaceutical intermediates and APIs required in the life cycle.
Lizhuo Pharmaceutical is a comprehensive technology enterprise focusing on the R&D, production and sales of pharmaceutical intermediates, mainly developing and producing anti-tumor, psychotropic, antiviral, hypoglycemic and antibacterial pharmaceutical intermediates. Our company also engaged in developing innovative drug intermediates according to the situation of the new drug market, and at the same time, develop and customize new drug intermediates according to the needs of customers.
Company Culture [https://www.shlzpharma.com/about-us/]
Lizhuo Pharmaceutical has always adhered to the principle of "keeping promises and honoring promises" and the business philosophy of "excellence, continuous improvement, innovation and development, openness and sharing", striving to provide professional and fast technology and production services, and striving to be a first-class pharmaceutical intermediate and API companies.
Our company has a complete R&D, pilot and scale-up production base. Currently, we have one 1,000-square-meter R&D laboratory, 2 pilot production workshops in Wuhan, equipped with twenty 50L-1000L reactors, high and low temperature Circulation device (-40 degrees C-200 degrees C), ultra-low temperature reaction device (-120 degrees C), vacuum and atmospheric distillation tower (2-6 meters), molecular distillation, solid distillation and other advanced equipment, can undertake ultra-low temperature reaction, format Continuous reaction, nitration reaction, nitro reduction reaction, epoxidation synthesis reaction, solid-liquid distillation and rectification and other production processes, the research and development center can undertake the customization of pharmaceutical intermediates from grams to kilograms, and the pilot production workshop and factory can Produce hundreds of kilograms to tons of products.
The researchers of Lizhuo Pharmaceutical are all doctoral and master technicians who have been engaged in the pharmaceutical synthesis business for many years. They have certain research and achievements in the technical field, and they also have rich practical experience in engineering amplification. At the same time, we also cooperate with Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, School of Pharmacy, Zhejiang University, School of Pharmacy, Zhejiang University of Technology and other institutions to develop projects, so as to promote the research and development of new drugs faster and better, and have achieved a number of research results.
Media Contact
Company Name: Shanghai Lizhuo Pharmaceutical Technology Co.,Ltd.
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=lizhuo-pharmaceutical-technology-empagliflozin-intermediate-3-cas-no-1279691369]
Country: China
Website: https://www.shlzpharma.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lizhuo Pharmaceutical Technology: Empagliflozin Intermediate 3 CAS NO. 1279691-36-9 here
News-ID: 3872066 • Views: …
More Releases from ABNewswire
Highland Forge Design Launches as a One-Craftsman Workshop Proving That Handmade …
At a time when consumers increasingly question the origins and quality of what they buy, Highland Forge Design offers a transparent alternative. Every product is handcrafted by a single artisan in Maryland who personally oversees each item from raw material to finished piece, ensuring nothing leaves the workshop without meeting his standard.
The modern consumer faces a paradox of choice. Thousands of products are available at the click of a button,…
Speedy Sparkle Cleaning Services Brings Dedicated House Cleaning to Every Vancou …
Vancouver's flat-rate residential cleaning company now serves every neighbourhood in the City of Vancouver with transparent pricing from $249, background-checked professionals, and same-day availability. No phone call required to book.
VANCOUVER, BC - July 11, 2026 - Speedy Sparkle Cleaning Services today announced the launch of dedicated house cleaning services across Vancouver [https://speedysparklecleaning.com/location/vancouver/], BC. The company now serves every neighbourhood in the City of Vancouver, including Kitsilano, Yaletown, Downtown, East Vancouver,…
How Unusual Home Features Influence Simpsonville Local Movers and Moving Service …
Swamp Rabbit Moving addresses how unusual home features shape the moving service needs in Simpsonville, from spiral staircases to specialty items, with free, itemized estimates tailored to each property's specific access challenges.
A move that looks simple on paper can become significantly more complex once the actual property layout comes into focus. Homes across Simpsonville and the surrounding Greenville County area exhibit a wide range of structural characteristics that directly affect…
How to Prepare for a Long-Distance Move to Greenville: Key Considerations for a …
Swamp Rabbit Moving, a trusted moving company Greenville relies on, outlines key steps for long distance movers planning a relocation to Upstate SC.
Relocations to Greenville, South Carolina, continue to climb as more households from across the country set their sights on the Upstate region. As interstate move volume grows, the demand for structured, professional relocation planning has grown alongside it. Swamp Rabbit Moving, a trusted moving company Greenville residents and…
More Releases for Empagliflozin
Top Market Shifts Transforming the Empagliflozin, Dapagliflozin And Canagliflozi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Empagliflozin, Dapagliflozin And Canagliflozin Market Through 2025?
In recent times, the market size for empagliflozin, dapagliflozin, and canagliflozin has consistently expanded. Projected growth suggests an increase from $9.64 billion in 2024 to $9.94 billion in 2025, marking a compound annual growth rate…
Empagliflozin Impurity Standards: Ensuring Uncompromised Drug Quality with Preci …
Empagliflozin, a widely prescribed medication for managing Type 2 diabetes, has revolutionized the approach to treatment by enabling better glycemic control and reducing cardiovascular risks. As its demand grows, so does the need for impeccable quality standards to ensure its efficacy and safety for patients worldwide. Integral to achieving this is the availability of well-characterized impurity standards, which form the cornerstone for rigorous quality testing.
To meet these precise requirements, Empagliflozin…
Empagliflozin, Dapagliflozin And Canagliflozin Market Report By Size, Share And …
The Business Research Company recently released a comprehensive report on the Global Empagliflozin, Dapagliflozin And Canagliflozin Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free…
Empagliflozin, Dapagliflozin And Canagliflozin Market Size, Share Analysis And T …
The new report published by The Business Research Company, titled Empagliflozin, Dapagliflozin And Canagliflozin Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the empagliflozin, dapagliflozin and canagliflozin market size has grown steadily in recent years. It will grow from…
Empagliflozin, Dapagliflozin and Canagliflozin Market Research Report 2023: …
Empagliflozin, Dapagliflozin and Canagliflozin are three main types of SGLT-2 inhibitors.
Global Empagliflozin, Dapagliflozin and Canagliflozin Market: Driven factors and Restrictions factors
The research report encompasses a comprehensive analysis of the factors that affect the growth of the market. It includes an evaluation of trends, restraints, and drivers that influence the market positively or negatively. The report also outlines the potential impact of different segments and applications on the market in the…
Empagliflozin Tablets Market Opportunities and Growth Challenges Report 2022-203 …
Global Empagliflozin Tablets Market 2022-2028 - Global Industry Size, Supply Analysis, Price Analysis, Consumption and Production, Supplier and Cost Structure Analysis
Empagliflozin Tablets Market Overview
The recent market intelligence study by the research analysts at Market Business Insights (MBI) takes a deep dive into inner operations of the global Empagliflozin Tablets Market. It thoroughly examines the market landscape to give the readers an accurate insight into the current, as well as the…
